Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
4018 | 672 | 43.1 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
518 | 3 | ANGIOGENESIS//RETINOPATHY OF PREMATURITY//ENDOSTATIN | 20826 |
4018 | 2 | PEDF//PIGMENT EPITHELIUM DERIVED FACTOR//PIGMENT EPITHELIUM DERIVED FACTOR PEDF | 672 |
16123 | 1 | PEDF//PIGMENT EPITHELIUM DERIVED FACTOR//PIGMENT EPITHELIUM DERIVED FACTOR PEDF | 672 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PEDF | authKW | 5072317 | 23% | 72% | 156 |
2 | PIGMENT EPITHELIUM DERIVED FACTOR | authKW | 4447563 | 21% | 69% | 142 |
3 | PIGMENT EPITHELIUM DERIVED FACTOR PEDF | authKW | 828846 | 3% | 79% | 23 |
4 | SECT PROT STRUCT FUNCT | address | 451703 | 2% | 76% | 13 |
5 | PATHOPHYSIOL THER EUT DIABET VASC COMPLIC | address | 361778 | 6% | 20% | 39 |
6 | IL MORPHOL | address | 202402 | 1% | 64% | 7 |
7 | PEDF R | authKW | 181753 | 1% | 100% | 4 |
8 | EPC 1 | authKW | 145401 | 1% | 80% | 4 |
9 | RADIOISOTOPE BASIC CLIN MED | address | 144868 | 2% | 25% | 13 |
10 | FUNCT MOL MARINE MICROORGANISMS | address | 141981 | 1% | 31% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Ophthalmology | 2407 | 17% | 0% | 111 |
2 | Medicine, Research & Experimental | 579 | 12% | 0% | 80 |
3 | Endocrinology & Metabolism | 381 | 10% | 0% | 69 |
4 | Biochemistry & Molecular Biology | 338 | 22% | 0% | 149 |
5 | Cell Biology | 295 | 13% | 0% | 84 |
6 | Oncology | 178 | 10% | 0% | 70 |
7 | Neurosciences | 51 | 8% | 0% | 52 |
8 | Pharmacology & Pharmacy | 50 | 8% | 0% | 52 |
9 | Pathology | 43 | 3% | 0% | 20 |
10 | Biotechnology & Applied Microbiology | 43 | 5% | 0% | 33 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SECT PROT STRUCT FUNCT | 451703 | 2% | 76% | 13 |
2 | PATHOPHYSIOL THER EUT DIABET VASC COMPLIC | 361778 | 6% | 20% | 39 |
3 | IL MORPHOL | 202402 | 1% | 64% | 7 |
4 | RADIOISOTOPE BASIC CLIN MED | 144868 | 2% | 25% | 13 |
5 | FUNCT MOL MARINE MICROORGANISMS | 141981 | 1% | 31% | 10 |
6 | RETINAL CELL MOL BIOL | 127596 | 3% | 13% | 21 |
7 | CHINA TROP DIS CONTROL | 116311 | 1% | 32% | 8 |
8 | KALASALINGAM EDUC | 102228 | 1% | 38% | 6 |
9 | IVF INFERTIL UNIT OBSTET GYNECOL | 90876 | 0% | 100% | 2 |
10 | NEUROTROPH TORS SECT | 81133 | 1% | 36% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CURRENT MOLECULAR MEDICINE | 3188 | 1% | 1% | 9 |
2 | MOLECULAR VISION | 2316 | 2% | 0% | 13 |
3 | INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 1554 | 4% | 0% | 26 |
4 | EXPERIMENTAL EYE RESEARCH | 1540 | 2% | 0% | 15 |
5 | MICROVASCULAR RESEARCH | 1374 | 1% | 0% | 9 |
6 | NATO ADVANCED SCIENCE INSTITUTES SERIES, SERIES A, LIFE SCIENCES | 1133 | 0% | 1% | 3 |
7 | JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY | 941 | 1% | 0% | 6 |
8 | TRENDS IN MOLECULAR MEDICINE | 584 | 1% | 0% | 4 |
9 | INTERNATIONAL JOURNAL OF OPHTHALMOLOGY | 508 | 1% | 0% | 4 |
10 | JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES | 438 | 1% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PEDF | 5072317 | 23% | 72% | 156 | Search PEDF | Search PEDF |
2 | PIGMENT EPITHELIUM DERIVED FACTOR | 4447563 | 21% | 69% | 142 | Search PIGMENT+EPITHELIUM+DERIVED+FACTOR | Search PIGMENT+EPITHELIUM+DERIVED+FACTOR |
3 | PIGMENT EPITHELIUM DERIVED FACTOR PEDF | 828846 | 3% | 79% | 23 | Search PIGMENT+EPITHELIUM+DERIVED+FACTOR+PEDF | Search PIGMENT+EPITHELIUM+DERIVED+FACTOR+PEDF |
4 | PEDF R | 181753 | 1% | 100% | 4 | Search PEDF+R | Search PEDF+R |
5 | EPC 1 | 145401 | 1% | 80% | 4 | Search EPC+1 | Search EPC+1 |
6 | PIGMENT EPITHELIUM DERIVED FACTOR GENE | 136315 | 0% | 100% | 3 | Search PIGMENT+EPITHELIUM+DERIVED+FACTOR+GENE | Search PIGMENT+EPITHELIUM+DERIVED+FACTOR+GENE |
7 | PIGMENT EPITHELIAL DERIVED FACTOR | 132174 | 1% | 36% | 8 | Search PIGMENT+EPITHELIAL+DERIVED+FACTOR | Search PIGMENT+EPITHELIAL+DERIVED+FACTOR |
8 | PEDF RECEPTOR | 90876 | 0% | 100% | 2 | Search PEDF+RECEPTOR | Search PEDF+RECEPTOR |
9 | 12 15 HETES | 45438 | 0% | 100% | 1 | Search 12+15+HETES | Search 12+15+HETES |
10 | 44MER | 45438 | 0% | 100% | 1 | Search 44MER | Search 44MER |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BECERRA, SP , NOTARIO, V , (2013) THE EFFECTS OF PEDF ON CANCER BIOLOGY: MECHANISMS OF ACTION AND THERAPEUTIC POTENTIAL.NATURE REVIEWS CANCER. VOL. 13. ISSUE 4. P. 258-271 | 135 | 80% | 60 |
2 | CRAWORD, SE , FITCHEV, P , VELICEASA, D , VOLPERT, OV , (2013) THE MANY FACETS OF PEDF IN DRUG DISCOVERY AND DISEASE: A DIAMOND IN THE ROUGH OR SPLIT PERSONALITY DISORDER?.EXPERT OPINION ON DRUG DISCOVERY. VOL. 8. ISSUE 7. P. 769 -792 | 145 | 76% | 15 |
3 | HE, XM , CHENG, R , BENYAJATI, S , MA, JX , (2015) PEDF AND ITS ROLES IN PHYSIOLOGICAL AND PATHOLOGICAL CONDITIONS: IMPLICATION IN DIABETIC AND HYPOXIA-INDUCED ANGIOGENIC DISEASES.CLINICAL SCIENCE. VOL. 128. ISSUE 11. P. 805 -823 | 95 | 74% | 6 |
4 | BELKACEMI, L , ZHANG, SX , (2016) ANTI-TUMOR EFFECTS OF PIGMENT EPITHELIUM-DERIVED FACTOR (PEDF): IMPLICATION FOR CANCER THERAPY. A MINI-REVIEW.JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. VOL. 35. ISSUE . P. - | 93 | 67% | 0 |
5 | FRANCO-CHUAIRE, ML , RAMIREZ-CLAVIJO, S , CHUAIRE-NOACK, L , (2015) PIGMENT EPITHELIUM-DERIVED FACTOR: CLINICAL SIGNIFICANCE IN ESTROGEN-DEPENDENT TISSUES AND ITS POTENTIAL IN CANCER THERAPY.IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES. VOL. 18. ISSUE 9. P. 837 -855 | 96 | 62% | 1 |
6 | YAMAGISHI, S , MATSUI, T , (2014) PIGMENT EPITHELIUM-DERIVED FACTOR (PEDF) AND CARDIOMETABOLIC DISORDERS.CURRENT PHARMACEUTICAL DESIGN. VOL. 20. ISSUE 14. P. 2377 -2386 | 85 | 62% | 2 |
7 | FILLEUR, S , NELIUS, T , DE RIESE, W , KENNEDY, RC , (2009) CHARACTERIZATION OF PEDF: A MULTI-FUNCTIONAL SERPIN FAMILY PROTEIN.JOURNAL OF CELLULAR BIOCHEMISTRY. VOL. 106. ISSUE 5. P. 769-775 | 54 | 87% | 111 |
8 | KAWAGUCHI, T , YAMAGISHI, SI , SATA, M , (2010) STRUCTURE-FUNCTION RELATIONSHIPS OF PEDF.CURRENT MOLECULAR MEDICINE. VOL. 10. ISSUE 3. P. 302-311 | 77 | 62% | 25 |
9 | HAN, J , GUO, J , (2015) CURRENT EVIDENCE AND POTENTIAL MECHANISMS OF THERAPEUTIC ACTION OF PEDF IN CERVICAL CANCER TREATMENT.CURRENT MOLECULAR MEDICINE. VOL. 15. ISSUE 5. P. 446 -455 | 59 | 68% | 3 |
10 | BARNSTABLE, CJ , TOMBRAN-TINK, J , (2004) NEUROPROTECTIVE AND ANTIANGIOGENIC ACTIONS OF PEDF IN THE EYE: MOLECULAR TARGETS AND THERAPEUTIC POTENTIAL.PROGRESS IN RETINAL AND EYE RESEARCH. VOL. 23. ISSUE 5. P. 561-577 | 56 | 73% | 114 |
Classes with closest relation at Level 2 |